Cargando…

Classification of Cells in CTC-Enriched Samples by Advanced Image Analysis

In the CellSearch(®) system, blood is immunomagnetically enriched for epithelial cell adhesion molecule (EpCAM) expression and cells are stained with the nucleic acid dye 4′6-diamidino-2-phenylindole (DAPI), Cytokeratin-PE (CK), and CD45-APC. Only DAPI+/CK+ objects are presented to the operator to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Wit, Sanne, Zeune, Leonie L., Hiltermann, T. Jeroen N., Groen, Harry J. M., van Dalum, Guus, Terstappen, Leon W. M. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210778/ https://www.ncbi.nlm.nih.gov/pubmed/30308977 http://dx.doi.org/10.3390/cancers10100377

Ejemplares similares

How to Agree on a CTC: Evaluating the Consensus in Circulating Tumor Cell Scoring
por: Zeune, Leonie L., et al.
Publicado: (2018)

Magnetic Particles for CTC Enrichment
por: Liu, Peng, et al.
Publicado: (2020)

The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015)

Detection of Circulating Tumor Cells
por: de Wit, Sanne, et al.
Publicado: (2014)

Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors
por: Tamminga, Menno, et al.
Publicado: (2019)

Optimal Halbach Configuration for Flow-through Immunomagnetic CTC Enrichment
por: Stevens, Michiel, et al.
Publicado: (2021)

Leukocyte-Derived Extracellular Vesicles in Blood with and without EpCAM Enrichment
por: Nanou, Afroditi, et al.
Publicado: (2019)

Filtration Parameters Influencing Circulating Tumor Cell Enrichment from Whole Blood
por: Coumans, Frank A. W., et al.
Publicado: (2013)

Filter Characteristics Influencing Circulating Tumor Cell Enrichment from Whole Blood
por: Coumans, Frank A. W., et al.
Publicado: (2013)

Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival
por: Nanou, Afroditi, et al.
Publicado: (2020)

Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
por: Barradas, Ana M.C., et al.
Publicado: (2013)

Quantifying HER-2 expression on circulating tumor cells by ACCEPT
por: Zeune, Leonie, et al.
Publicado: (2017)

Metastasis and Circulating Tumor Cells
por: van Dalum, Guus, et al.
Publicado: (2012)

Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients
por: Nanou, Afroditi, et al.
Publicado: (2018)

Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients
por: Tamminga, Menno, et al.
Publicado: (2020)

Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)
por: Andree, Kiki C., et al.
Publicado: (2018)

Magnetic-Based Enrichment of Rare Cells from High Concentrated Blood Samples
por: Wu, Junhao, et al.
Publicado: (2020)

Aneuploid CTC and CEC
por: Lin, Peter Ping
Publicado: (2018)

Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential
por: Markiewicz, Aleksandra, et al.
Publicado: (2014)

Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis
por: Stoecklein, Nikolas H., et al.
Publicado: (2023)

Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch(®) and ISET
por: Tamminga, Menno, et al.
Publicado: (2020)

HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer
por: Nanou, Afroditi, et al.
Publicado: (2020)

The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma
por: Yi, Bin, et al.
Publicado: (2021)

Development and clinical validation of a microfluidic-based platform for CTC enrichment and downstream molecular analysis
por: Cai, Songhua, et al.
Publicado: (2023)

Recent Update Roles of Magnetic Nanoparticles in Circulating Tumor Cell (CTC)/Non-CTC Separation
por: Pipatwatcharadate, Chawapon, et al.
Publicado: (2023)

Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients
por: Mendelaar, Pauline A. J., et al.
Publicado: (2020)

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization
por: Werner, Shannon L., et al.
Publicado: (2015)

Correction to: The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma
por: Yi, Bin, et al.
Publicado: (2021)

Premio literario CTC : Concurso Rubén Martínez Villena.
Publicado: (1976)

Efficiency of whole genome amplification of single circulating tumor cells enriched by CellSearch and sorted by FACS
por: Swennenhuis, Joost F, et al.
Publicado: (2013)

Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery
por: Payne, Karl, et al.
Publicado: (2021)

A New Method for CTC Images Recognition Based on Machine Learning
por: He, Binsheng, et al.
Publicado: (2020)

Insights on CTC Biology and Clinical Impact Emerging from Advances in Capture Technology
por: Bailey, Patrick C., et al.
Publicado: (2019)

Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing
por: Saber, Ali, et al.
Publicado: (2016)

The application of nano-enrichment in CTC detection and the clinical significance of CTCs in non-small cell lung cancer (NSCLC) treatment
por: Wei, Tengteng, et al.
Publicado: (2019)

Technical Challenges for CTC Implementation in Breast Cancer
por: Ramos-Medina, Rocío, et al.
Publicado: (2021)

EXTRACOLONIC FINDINGS—IDENTIFICATION AT LOW-DOSE CTC
por: Thorén, Fredrik, et al.
Publicado: (2021)

Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors
por: van der Leest, Paul, et al.
Publicado: (2021)

Immune microenvironment composition in non‐small cell lung cancer and its association with survival
por: Tamminga, Menno, et al.
Publicado: (2020)

Improvement in Hemorrhoidal Disease Surgery Outcomes Using a New Anatomical/Clinical–Therapeutic Classification (A/CTC)
por: Naldini, Gabriele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4dj5otgj145bh4rmla5ioa6otg